These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Amantadine in drug-induced extrapyramidal signs: a comparative study. Ananth J; Sangani H; Noonan JP Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):323-6. PubMed ID: 239908 [TBL] [Abstract][Full Text] [Related]
8. [Edemas and myocloni concerning a patient with Parkinson's disease treated by amantadine (author's transl)]. Chevalier JF; Renier E; Brion S Encephale; 1980; 6(4):381-4. PubMed ID: 7439114 [TBL] [Abstract][Full Text] [Related]
9. Development of tolerance to the therapeutic effect of amantadine on akathisia. Zubenko GS; Barreira P; Lipinski JF J Clin Psychopharmacol; 1984 Aug; 4(4):218-20. PubMed ID: 6470196 [TBL] [Abstract][Full Text] [Related]
10. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients. Silver H; Geraisy N; Schwartz M J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856 [TBL] [Abstract][Full Text] [Related]
11. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes]. Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408 [No Abstract] [Full Text] [Related]
12. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel). Merrick EM; Schmitt PP Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529 [No Abstract] [Full Text] [Related]
13. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome]. Kadykov AS Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):174-8. PubMed ID: 944514 [TBL] [Abstract][Full Text] [Related]
14. The effect of amantadine on neuroleptic-induced parkinsonism. Rüther E; Fussmann-Hegewald M; Eben E Act Nerv Super (Praha); 1973 May; 15(2):93. PubMed ID: 4148089 [No Abstract] [Full Text] [Related]
15. [Current medical treatment of Parkinsonian syndromes]. Cincă I; Bulandra R; Serbănesco A; Ninosu N Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886 [No Abstract] [Full Text] [Related]
16. No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients. Silver H; Geraisy N Biol Psychiatry; 1995 Sep; 38(6):413-5. PubMed ID: 8547463 [No Abstract] [Full Text] [Related]
17. A controlled trial of amantadine in drug-induced extrapyramidal disorders. DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE Psychopharmacol Bull; 1977 Jul; 13(3):31-3. PubMed ID: 18755 [No Abstract] [Full Text] [Related]
18. [Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale]. Torrini M; Masini E; Ledda F; Mannaioni PF Clin Ter; 1981 Jun; 97(6):561-85. PubMed ID: 7023804 [No Abstract] [Full Text] [Related]
19. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs]. Bukowczyk A; Wasik A; Horodnicki J Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321 [No Abstract] [Full Text] [Related]
20. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics]. Fanali A; Nardini M; Sorgona F Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245 [No Abstract] [Full Text] [Related] [Next] [New Search]